Hyperlipidemias
169
13
20
116
Key Insights
Highlights
Success Rate
97% trial completion (above average)
Published Results
23 trials with published results (14%)
Research Maturity
116 completed trials (69% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
2.4%
4 terminated out of 169 trials
96.7%
+10.1% vs benchmark
12%
20 trials in Phase 3/4
20%
23 of 116 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 116 completed trials
Clinical Trials (169)
Effect of Omega-3 Supplementation on Fasting Triglycerides During Lifestyle Intervention in Adults With Mild-to-moderate Hypertriglyceridemia
Improving How Older Adults at Risk for Cardiovascular Outcomes Are Selected for Care Coordination
PCSK 9 Inhibitor Added to High-Intensity Statin Therapy to Prevent Cardiovascular Events in Patients With ACS After PCI
Food is Medicine vs Lifestyle Medicine For Cardiovascular Kidney Metabolic (CKM) Syndrome
Virtual Diabetes Group Visits Across Health Systems
A Study to Assess the Effect of HRS-1301 on the Pharmacokinetics of Midazolam and Atorvastatin in Healthy Participants
Combined Effects of Withania Somnifera & Syzgium Cumini on Hyperlipidemia
Social Needs Screening and Chronic Diseases Study (WE CARE)
A Study of HRS-1301 Tablets in Healthy Subjects and Those With Impaired Kidney Function
A Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of DWC202206 and DWC202207 in Patients With Concomitant Hypertension and Hyperlipidemia
Lipid Management in Renal Transplant Recipients Using Evolocumab.
Penn Medicine Healthy Heart
Imaging the Pathogenesis of Cerebral Small Vessel Disease
Developing a Learning COmmunity to Increase eNgagemeNt and Enrollment in Cardiovascular Clinical Trials (CONNECT)
A Study of SAL003 in Participants With Hypercholesterolemia and Mixed Dyslipidemia
Centralized Prescribing for Statins
Biological Sample Repository for Gastrointestinal Disorders
Cardiovascular Risk Assessment for Patients With Rheumatoid Arthritis Arthritis:
Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention
The Role of Proprotein-convertase-subtilisin/Kexin-type 9 in Kidney Damage in Nephrotic Syndrom